Apellis Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
34
0.08
(0.236%)
Volume:
0
52 week range:
27.5 - 73
Market Cap:
2.958B
Company Description:
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, the company aims to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology.